Falls Prevention Program for At-Risk Adults
Trial Summary
The trial does not specify if you need to stop taking your current medications. However, if you are taking prescription anti-coagulants, you need physician clearance to participate.
Research shows that community-based fall prevention programs can help reduce falls in older adults by identifying risks and providing appropriate interventions. These programs have been effective in some studies, although results can vary depending on how they are implemented.
12345The Falls Prevention Program, under various names, has been implemented in community settings and involves activities like exercise, eye exams, and home safety checks. These programs are generally safe and aim to increase safety awareness and knowledge among older adults, helping them live independently and safely.
56789The Falls Prevention Program is unique because it is a community-based approach that combines multiple strategies, such as exercise, home hazard assessments, and health screenings, to address various risk factors for falls, making it more comprehensive than single-strategy treatments.
710111213Eligibility Criteria
This trial is for adults aged 18-100 who are at risk of falling, can attend sessions twice a week for five weeks, and have medical clearance to participate. They should be able to perform basic mobility tasks like getting up from a chair in less than 45 seconds. People on anti-coagulants without doctor's approval or those unable to kneel or sit on the floor aren't eligible.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Falls Prevention Training
Participants complete 10 sessions of falls prevention training, including obstacle course training, falls strategies, and walking and balance exercises.
Follow-up
Participants are monitored for changes in postural assessment, fall risk, and balance confidence from baseline to 1-year post intervention.
Participant Groups
Falls Prevention Program is already approved in United States, European Union, Canada for the following indications:
- Prevention of falls and fall-related injuries in adults at risk
- Reduction of falls risk in older adults
- Improvement of functional mobility in adults at risk for falls
- Prevention of falls in community-dwelling older adults
- Reduction of fall-related injuries